Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Candamo-Lourido

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biomacromolecules|April 8, 2022
New Perspectives for Developing Therapeutic Bioconjugates of Metabolite-Depleting Enzymes: Lessons Learned Combating Glutamate ExcitotoxicityAhlem Zaghmi, María Pérez-Mato, Antonio Dopico-López, et al.
Journal of Clinical Medicine|February 25, 2022
Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with StrokePaulo Ávila-Gómez, María Pérez-Mato, Pablo Hervella, et al.
Frontiers in Molecular Biosciences|May 9, 2022
Involvement of Ceramide Metabolism in Cerebral IschemiaAlberto Ouro, Clara Correa-Paz, Elena Maqueda, et al.
International Journal of Molecular Sciences|July 27, 2024
Comparative Brain Proteomic Analysis between Sham and Cerebral Ischemia Experimental GroupsMaría Candamo-Lourido, Antonio Dopico-López, Esteban López-Arias, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 4, 2024
Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute strokeClara Correa-Paz, María Pérez-Mato, Mathys Bellemain-Sagnard, et al.
Iscience|November 11, 2024
Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic strokeMaría Pérez-Mato, Antonio Dopico-López, Yunus Akkoc, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biomacromolecules|April 8, 2022
New Perspectives for Developing Therapeutic Bioconjugates of Metabolite-Depleting Enzymes: Lessons Learned Combating Glutamate ExcitotoxicityAhlem Zaghmi, María Pérez-Mato, Antonio Dopico-López, et al.
Journal of Clinical Medicine|February 25, 2022
Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with StrokePaulo Ávila-Gómez, María Pérez-Mato, Pablo Hervella, et al.
Frontiers in Molecular Biosciences|May 9, 2022
Involvement of Ceramide Metabolism in Cerebral IschemiaAlberto Ouro, Clara Correa-Paz, Elena Maqueda, et al.
International Journal of Molecular Sciences|July 27, 2024
Comparative Brain Proteomic Analysis between Sham and Cerebral Ischemia Experimental GroupsMaría Candamo-Lourido, Antonio Dopico-López, Esteban López-Arias, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 4, 2024
Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute strokeClara Correa-Paz, María Pérez-Mato, Mathys Bellemain-Sagnard, et al.
Iscience|November 11, 2024
Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic strokeMaría Pérez-Mato, Antonio Dopico-López, Yunus Akkoc, et al.
Pageof 1